These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of somatostatin in the study of carbohydrate homeostasis in man: physiologic, pathologic, and therapeutic considerations. Gerich JE Adv Exp Med Biol; 1977; 87():299-318. PubMed ID: 143198 [No Abstract] [Full Text] [Related]
7. Clinical control of diabetes by the artificial pancreas. Albisser AM; Leibel BS; Ewart TG; Davidovac Z; Botz CK; Zingg W; Schipper H; Gander R Diabetes; 1974 May; 23(5):397-404. PubMed ID: 4598090 [No Abstract] [Full Text] [Related]
8. Substitution of islet cell function by mechanical device: extracorporeal artificial pancreas. Pfeiffer EF; Kerner W; Beischer W Adv Exp Med Biol; 1979; 119():501-8. PubMed ID: 386732 [No Abstract] [Full Text] [Related]
9. The therapy of diabetes. Maurer AC Am Sci; 1979; 67(4):422-31. PubMed ID: 119452 [No Abstract] [Full Text] [Related]
10. Pancreas transplantation and the artificial pancreas: status of current experimental approaches. Felts PW South Med J; 1973 Jan; 66(1):66-73. PubMed ID: 4567170 [No Abstract] [Full Text] [Related]
12. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Shichiri M; Kawamori R; Abe H Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171 [TBL] [Abstract][Full Text] [Related]
14. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Pfeiffer EF; Thum C; Clemens AH Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598 [No Abstract] [Full Text] [Related]
15. Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas). Santeusanio F; Massi-Benedetti M; Angeletti G; Calabrese G; Bueti A; Brunetti P J Endocrinol Invest; 1981; 4(1):93-6. PubMed ID: 7016969 [TBL] [Abstract][Full Text] [Related]
16. [Artificial pancreas: clinical and therapeutic value in 11 patients (author's transl)]. Buysschaert M; Lambotte L; Lambert AE Nouv Presse Med; 1979 Jul 14-28; 8(32):2597-601. PubMed ID: 386266 [TBL] [Abstract][Full Text] [Related]
17. The development of an artificial endocrine pancreas and its application in research and clinical investigation. Albisser AM; Leibel BS; Zingg W; Botz CK; Marliss EB; Denoga A; Zinman B Horm Metab Res; 1977; Suppl 7():87-94. PubMed ID: 326653 [No Abstract] [Full Text] [Related]
18. Development of a closed-loop artificial pancreas. Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087 [TBL] [Abstract][Full Text] [Related]
19. The artificial endocrine pancreas: its impact on the pathophysiology and treatment of diabetes mellitus. Pfeiffer EF; Kerner W Diabetes Care; 1981; 4(1):11-26. PubMed ID: 7009107 [No Abstract] [Full Text] [Related]
20. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas. Lambert AE; Buysschaert M; Lambotte L Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067 [No Abstract] [Full Text] [Related] [Next] [New Search]